Biography:

Dr. Hirotomo Dochi earned his MD and PhD from Kanazawa University, Japan. He completed clinical training in otolaryngology and focused his PhD research on Epstein-Barr virus (EBV)-associated cancers. He is currently a postdoctoral fellow in Dr. Lin’s lab at Tulane University and the Louisiana Cancer Research Center, where he studies EBV reactivation and host-virus interactions. Dr. Dochi has received multiple honors, including a travel award to present his work on EBV infection models at the 2024 International Symposium on EBV & KSHV. His goal is to advance translational oncology through a combination of clinical and molecular research.